The joint seminar and workshop from the British Pharmacological Society, Laboratory Animal Science Association (LASA) and Psychiatry Consortium was held on the 24th and 25th of February 2021, with…
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued new advice, concluding a possible link between the Oxford-AstraZeneca COVID-19 vaccine and extremely rare,…
Today, 5 April 2021, updated guidance on good practice in prescribing and managing medicines and devices, published by the General Medical Council (GMC) comes into force. The guidance supports…
As the season shifts from winter to spring in the UK, many of us are looking forward to the gradual easing of lockdown restrictions and the chance to connect, as per Government guidelines, with…
In its recent spending review, the government announced investment of £14.6 billion in R&D in 2021-22, building on commitments to increase public R&D investment to £22 billion per year by…
The British Pharmacological Society have partnered with Zinc Media to produce a series of complementary and informative films. These films will celebrate innovation and collaboration across the…
The Society welcomes publication of the Scottish Government’s new ‘Heart disease: action plan’. The action plan sets out the Government’s priorities and the actions they will take to minimise…
A little over a year ago, the UK confirmed its first case of COVID-19. Since then, we have collectively endured months of uncertainty and lockdowns whilst scientists worldwide endeavoured to create a…
The partnership between ELRIG UK and the British Pharmacological Society (BPS) is a strategic alliance that recognises the complementary strengths of the two organisations. By working together, the…
In 2020, as a result of the COVID-19 pandemic, the Society made the decision to pivot the annual meeting to an online event for the first time. The Meetings and Events team worked hard to…
